Givaudan | GIVN - Equity Capital And Reserves


Givaudan reported CHF4.54B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Air Liquide EUR 26.21B 1.7B Dec/2025
Akzo Nobel EUR 4.88B 222M Mar/2026
Anheuser-Busch USD 97.74B 6.32B Dec/2025
Arkema EUR 6.96B 913.9M Mar/2026
Associated British Foods GBP 11.06B 64M Dec/2025
BASF EUR 33.2B 434M Dec/2025
Bayer EUR 28.85B 2.9B Mar/2026
Beiersdorf EUR 8.6B 133M Dec/2025
British American Tobacco GBP 46.03B 1.14B Dec/2025
Covestro EUR 7B 908M Dec/2025
Croda International GBP 2.28B 53.3M Dec/2024
Danone EUR 16.92B 1.56B Dec/2025
Diageo GBP 11.6B 1.58B Dec/2025
Fresenius EUR 19.77B 1.14B Dec/2025
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
Givaudan CHF 4.54B 430M Dec/2025
Heineken EUR 20.61B 2.9B Dec/2025
Henkel EUR 20.5B 459M Dec/2025
International Flavors Fragrances USD 14.12B 34M Mar/2026
Johnson Matthey GBP 2.02B 85M Jun/2026
Kerry EUR 6.49B 27M Dec/2024
Lonza CHF 9.13B 513M Dec/2025
L'Oréal EUR 34.95B 3.78B Dec/2025
Merck EUR 29.74B 1.15B Mar/2026
Nestle CHF 32.81B 3.98B Dec/2025
Pernod Ricard EUR 3.44B 12.78B Dec/2025
Reckitt Benckiser GBP 6.7B 1.39B Dec/2024
SGS CHF 877M 188M Dec/2024
Sika AG CHF 6.66B 481.4M Dec/2025
Solvay EUR 1.18B 161M Mar/2026
Tate & Lyle GBP 1.6B 52M Jun/2026
Umicore EUR 2.24B 195.4M Dec/2025
Victrex GBP 361.9M 71.6M Jun/2026